Neuroinflammatory conditions

A two year clinical, immunological and gut-brain-axis prospective study to predict treatment response to cladribine tablets in relapsing-remitting multiple sclerosis

Study Overview This prospective study focuses on the clinical and immunological parameters connected to the treatment of relapsing-remitting multiple sclerosis

A two year clinical, immunological and gut-brain-axis prospective study to predict treatment response to cladribine tablets in relapsing-remitting multiple sclerosis Read Post »

Scroll to Top